Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Jul;18(1):142–147. doi: 10.1128/aac.18.1.142

Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection.

K F Soike, A D Felsenfeld, S Gibson, P J Gerone
PMCID: PMC283954  PMID: 6158291

Abstract

Adenine arabinoside and adenine arabinoside 5'-monophosphate (ara-AMP) have been evaluated for antiviral activity against simian varicella virus infection in monkeys. In a preliminary study for toxicity, intramuscular injection of ara-AMP at 15 mg/kg per day as a single injection for 5 days to two normal patas monkeys caused no detectable local reaction, no weight loss or changes in serum transaminase levels, and no hematological abnormalities. When this dose was given in the treatment of four simian varicella virus-infected patas monkeys, no effect was observed on the clinical course of infection, as compared with four infected monkeys which received phosphate-buffered saline. Treatment was begun 43 h after virus inoculation and was continued for 16 days. Toxicity of intravenously administered ara-AMP at 100 to 50 mg/kg per day for 5 days to pairs of uninfected patas monkeys was evident by hematological and hepatic histological alterations, as well as the death of one monkey in each pair. No gross evidence of toxicity occurred in two monkeys which received 20 mg of ara-AMP per kg per day. The antiviral efficacy of intravenous treatment was studied in groups of four African green monkeys which received adenine arabinoside at 15 mg/kg per day or ara-AMP at 18.4 mg/kg per day. Drug administration began 48 h after inoculation with simian varicella virus and continued for 10 days. The monkeys that received treatment did not respond to infection differently from four infected control monkeys similarly treated with phosphate-buffered saline.

Full text

PDF
142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alenius S., Oberg B. Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs. Arch Virol. 1978;58(4):277–288. doi: 10.1007/BF01317820. [DOI] [PubMed] [Google Scholar]
  2. Allen W. P., Felsenfeld A. D., Wolf R. H., Smetana H. F. Recent studies on the isolation and characterization of Delta herpesvirus. Lab Anim Sci. 1974 Feb;24(1):222–228. [PubMed] [Google Scholar]
  3. Collins P., Bauer D. J. Comparison of activity of herpes virus inhibitors. J Antimicrob Chemother. 1977 Mar;3 (Suppl A):73–81. doi: 10.1093/jac/3.suppl_a.73. [DOI] [PubMed] [Google Scholar]
  4. Felsenfeld A. D., Abee C. R., Gerone P. J., Soike K. F., Williams S. R. Phosphonoacetic acid in the treatment of simian varicella. Antimicrob Agents Chemother. 1978 Sep;14(3):331–335. doi: 10.1128/aac.14.3.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Felsenfeld A. D., Schmidt N. J. Antigenic relationships among several simian varicella-like viruses and varicella-zoster virus. Infect Immun. 1977 Mar;15(3):807–812. doi: 10.1128/iai.15.3.807-812.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Felsenfeld A. D., Schmidt N. J. Immunological relationship between delta herpesvirus of patas monkeys and varicells-zoster virus of humans. Infect Immun. 1975 Aug;12(2):261–266. doi: 10.1128/iai.12.2.261-266.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fiala M., Chow A. W., Miyasaki K., Guze L. B. Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH. J Infect Dis. 1974 Jan;129(1):82–85. doi: 10.1093/infdis/129.1.82. [DOI] [PubMed] [Google Scholar]
  8. Kern E. R., Richards J. T., Overall J. C., Jr, Glasgow L. A. Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphate. J Infect Dis. 1977 Apr;135(4):557–567. doi: 10.1093/infdis/135.4.557. [DOI] [PubMed] [Google Scholar]
  9. Marks M. I. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model. J Infect Dis. 1975 Jan;131(1):11–16. doi: 10.1093/infdis/131.1.11. [DOI] [PubMed] [Google Scholar]
  10. Wenner H. A., Barrick S., Abel D., Seshumurty P. The pathogenesis of simian varicella virus in cynomolgus monkeys. Proc Soc Exp Biol Med. 1975 Nov;150(2):318–323. doi: 10.3181/00379727-150-39027. [DOI] [PubMed] [Google Scholar]
  11. Whitley R. J., Soong S. J., Dolin R., Galasso G. J., Ch'ien L. T., Alford C. A. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11;297(6):289–294. doi: 10.1056/NEJM197708112970601. [DOI] [PubMed] [Google Scholar]
  12. Williams B. B., Lerner A. M. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus. J Infect Dis. 1975 Jun;131(6):673–677. doi: 10.1093/infdis/131.6.673. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES